Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IND. SWIFT vs AJANTA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IND. SWIFT AJANTA PHARMA IND. SWIFT/
AJANTA PHARMA
 
P/E (TTM) x 3.3 38.3 8.7% View Chart
P/BV x - 8.3 - View Chart
Dividend Yield % 0.0 0.3 -  

Financials

 IND. SWIFT   AJANTA PHARMA
EQUITY SHARE DATA
    IND. SWIFT
Mar-23
AJANTA PHARMA
Mar-23
IND. SWIFT/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs151,426 1.0%   
Low Rs71,062 0.6%   
Sales per share (Unadj.) Rs75.9297.2 25.5%  
Earnings per share (Unadj.) Rs4.846.7 10.3%  
Cash flow per share (Unadj.) Rs10.157.1 17.7%  
Dividends per share (Unadj.) Rs07.00 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs-130.1269.1 -48.4%  
Shares outstanding (eoy) m54.16125.91 43.0%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.14.2 3.3%   
Avg P/E ratio x2.226.6 8.3%  
P/CF ratio (eoy) x1.021.8 4.8%  
Price / Book Value ratio x-0.14.6 -1.8%  
Dividend payout %015.0 0.0%   
Avg Mkt Cap Rs m572156,638 0.4%   
No. of employees `000NANA-   
Total wages/salary Rs m6377,851 8.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m4,11037,426 11.0%  
Other income Rs m119986 12.0%   
Total revenues Rs m4,22838,413 11.0%   
Gross profit Rs m1,0267,833 13.1%  
Depreciation Rs m2871,308 21.9%   
Interest Rs m59858 1,023.3%   
Profit before tax Rs m2607,453 3.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m01,573 0.0%   
Profit after tax Rs m2605,880 4.4%  
Gross profit margin %25.020.9 119.3%  
Effective tax rate %021.1 0.0%   
Net profit margin %6.315.7 40.3%  
BALANCE SHEET DATA
Current assets Rs m2,73428,252 9.7%   
Current liabilities Rs m9,36311,393 82.2%   
Net working cap to sales %-161.345.0 -358.1%  
Current ratio x0.32.5 11.8%  
Inventory Days Days11566 174.9%  
Debtors Days Days92910 9,011.8%  
Net fixed assets Rs m3,75818,707 20.1%   
Share capital Rs m108253 42.9%   
"Free" reserves Rs m-7,15533,624 -21.3%   
Net worth Rs m-7,04733,877 -20.8%   
Long term debt Rs m4,03113 32,248.9%   
Total assets Rs m6,49247,047 13.8%  
Interest coverage x1.4128.6 1.1%   
Debt to equity ratio x-0.60 -155,027.8%  
Sales to assets ratio x0.60.8 79.6%   
Return on assets %13.212.6 104.7%  
Return on equity %-3.717.4 -21.3%  
Return on capital %-28.422.2 -128.4%  
Exports to sales %68.859.9 114.8%   
Imports to sales %5.311.5 46.1%   
Exports (fob) Rs m2,82722,420 12.6%   
Imports (cif) Rs m2174,293 5.1%   
Fx inflow Rs m2,94722,420 13.1%   
Fx outflow Rs m3134,293 7.3%   
Net fx Rs m2,63418,127 14.5%   
CASH FLOW
From Operations Rs m7307,918 9.2%  
From Investments Rs m-293-5,596 5.2%  
From Financial Activity Rs m-466-1,079 43.2%  
Net Cashflow Rs m-291,243 -2.3%  

Share Holding

Indian Promoters % 55.6 66.2 83.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 25.8 -  
FIIs % 0.0 9.1 -  
ADR/GDR % 0.0 0.0 -  
Free float % 44.4 33.8 131.5%  
Shareholders   14,219 54,351 26.2%  
Pledged promoter(s) holding % 42.8 12.3 347.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IND. SWIFT With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on IND. SWIFT vs AJANTA PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

IND. SWIFT vs AJANTA PHARMA Share Price Performance

Period IND. SWIFT AJANTA PHARMA S&P BSE HEALTHCARE
1-Day 8.28% 2.51% 1.18%
1-Month -2.97% 7.60% -0.75%
1-Year 161.80% 92.91% 61.82%
3-Year CAGR 59.03% 21.63% 18.16%
5-Year CAGR 27.79% 26.85% 19.79%

* Compound Annual Growth Rate

Here are more details on the IND. SWIFT share price and the AJANTA PHARMA share price.

Moving on to shareholding structures...

The promoters of IND. SWIFT hold a 55.6% stake in the company. In case of AJANTA PHARMA the stake stands at 66.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IND. SWIFT and the shareholding pattern of AJANTA PHARMA.

Finally, a word on dividends...

In the most recent financial year, IND. SWIFT paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

AJANTA PHARMA paid Rs 7.0, and its dividend payout ratio stood at 15.0%.

You may visit here to review the dividend history of IND. SWIFT, and the dividend history of AJANTA PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.